Unknown PHASE4 INTERVENTIONAL 2-arm NCT00202358

Perioperative Effect of Atenolol on Cytokine Profiles

The Effect of Perioperative Atenolol on Post-Operative Cytokines

Sponsor: Medtronic - MITG

Conditions Surgery

Updated 5 times since 2017 Last updated: Jun 13, 2008 Started: Nov 30, 2002 Primary completion: Nov 30, 2007 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00202358, this PHASE4 trial focuses on Surgery and remains ongoing. Sponsored by Medtronic - MITG, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Nov 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic - MITG
Saini Foundation

Data source: Saini Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hyannis, United States